"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 |
| 1997 | 0 | 9 | 9 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 11 | 11 |
| 2000 | 0 | 6 | 6 |
| 2001 | 0 | 6 | 6 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 11 | 11 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 8 | 8 |
| 2006 | 0 | 12 | 12 |
| 2007 | 0 | 14 | 14 |
| 2008 | 0 | 14 | 14 |
| 2009 | 0 | 15 | 15 |
| 2010 | 0 | 19 | 19 |
| 2011 | 0 | 21 | 21 |
| 2012 | 0 | 17 | 17 |
| 2013 | 0 | 13 | 13 |
| 2014 | 1 | 15 | 16 |
| 2015 | 0 | 23 | 23 |
| 2016 | 0 | 24 | 24 |
| 2017 | 0 | 15 | 15 |
| 2018 | 0 | 34 | 34 |
| 2019 | 0 | 25 | 25 |
| 2020 | 0 | 35 | 35 |
| 2021 | 0 | 26 | 26 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 11 | 11 |
| 2024 | 0 | 23 | 23 |
| 2025 | 0 | 22 | 22 |
| 2026 | 0 | 15 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Clinical Practice Guidelines by Infectious Diseases Society of America: 2025 Guidelines on Management and Treatment of Complicated Urinary Tract Infections - Timing of Intravenous to Oral Antibiotics Transition for Complicated Urinary Tract Infections. Clin Infect Dis. 2026 08 24; 82(Suppl 3):i68-i78.
-
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation. Clin Pharmacokinet. 2026 Sep; 65(9):1389-1403.
-
Phase I study of oral azacitidine plus salvage chemotherapy in relapsed/refractory diffuse large B-cell lymphoma. Ann Hematol. 2026 Jun 22; 105(9).
-
Triple oral therapy combining metformin, SGLT-2 and DPP-4 inhibitors versus dual therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. Medicine (Baltimore). 2026 May 29; 105(22):e49050.
-
Discontinuation of Oral Anticoagulation After Successful Atrial Fibrillation Ablation - Are We Ready to Change Clinical Practice in 2026? Med Sci Monit. 2026 May 08; 32:e952757.
-
Treatment Adherence to Oral Direct-Acting Antiviral Agents in Hepatitis C Infection. Pharmacotherapy. 2026 May; 46(5):e70126.
-
Using the Comparing Oral versus Parenteral Antimicrobial Therapy (COPAT) Clinical Trial to Influence Institutional Practice Transformation Towards Earlier Transition to Oral Antibiotics. Clin Infect Dis. 2026 04 30; 82(4):e674-e681.
-
Age-Appropriate Low Dosing for Food Protein-Induced Enterocolitis Syndrome Oral Food Challenges: Proposing a Standardized Approach. J Allergy Clin Immunol Pract. 2026 07; 14(7):1570-1588.e2.
-
Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical Trial. J Am Coll Cardiol. 2026 Jul 21; 88(3):340-352.
-
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward. Expert Rev Gastroenterol Hepatol. 2026 Mar; 20(3):233-246.